Full-text search

Results for “Melvin Capital Master Fund Ltd”

Search across the indexed text of every released document.

1,670 documents found

I hope this letter finds you well — please see the below updates on the Park Mansion
document TEXT-001-HOUSE_OVERSIGHT_022417.txt Nov 23, 2015 House Oversight Committee — Epstein Estate Records (Nov 2025)

PARK PARTNERS 320 EAST 82 ST I NEW YORK I NY November 23, 2015 Dear Partner, I hope this letter finds you well — please see the below updates on the Park Mansion: I am happy to report that we have completed the building's demolition stage. I have included a few photos for your re...

Organizational Expenses: The Fund will bear expenses relating to the organization of the
document IMAGES-007-HOUSE_OVERSIGHT_024062.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Organizational Expenses: The Fund will bear expenses relating to the organization of the Fund and its affiliates and the offering of the Limited Partner Interests, including legal, accounting, travel, meeting, printing and other administrative expenses, up to an aggregate of $1,2...

prescription drug costs during the temporary “gap” from Medicare coverage until their
document IMAGES-007-HOUSE_OVERSIGHT_024072.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

prescription drug costs during the temporary “gap” from Medicare coverage until their prescription drug costs reach the threshold for catastrophic coverage by Medicare), (iii) an approval process for generic biologics and granting exclusive marketing rights to original manufactur...

RE: request
email TEXT-001-HOUSE_OVERSIGHT_016420.txt Jan 11, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

SUPREME COURT OF THE STATE OF NEW YORK APPELLATE DIVISION-FIRST DEPARTMENT ··-····-·············-·-····-·····-··-··-············-··-···· X THE PEOPLE OF THE STATE OF NEW YORK, App. Div. No. 6081 - against - JEFFREY E. EPSTEIN, Respondent, Defendant-Appellant. On Appeal from New...

Portfolio Company Leverage
document IMAGES-007-HOUSE_OVERSIGHT_024076.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Portfolio Company Leverage To the extent that any investment is made in a portfolio company with a leveraged capital structure, such investment will be subject to increased exposure to adverse economic factors such as a significant rise in interest rates, a severe downturn in th...

The Fund Managers have been an active investor in the medical device sector across the New
document IMAGES-007-HOUSE_OVERSIGHT_024034.txt Mar 31, 2014 House Oversight Committee — Epstein Estate Records (Nov 2025)

MEDICAL DEVICES RETURNS SUMMARY: The Fund Managers have been an active investor in the medical device sector across the New Leaf and Sprout Funds. Combined, the Fund Managers have invested $371 million in 29 medical device companies, and have gross realizations of $394 million a...

This Memorandum has been prepared for private information purposes only and it may not be used for,
document IMAGES-007-HOUSE_OVERSIGHT_024113.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

This Memorandum has been prepared for private information purposes only and it may not be used for, and shall not be deemed, a public offering of interests in the Fund. This Memorandum is strictly for private use by its holder and may not be passed on to third parties or otherwis...

New Leaf’s investment strategy is differentiated in the venture capital industry in terms of its
document IMAGES-007-HOUSE_OVERSIGHT_024042.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

V. NEW LEAF VENTURE PARTNERS INVESTMENT STRATEGY New Leaf’s investment strategy is differentiated in the venture capital industry in terms of its sector focus, specific approaches within each sector, and the depth of experience and long-term track record that supports each eleme...

New Leaf team five years ago and has made significant contributions to the NLV-II portfolio
document IMAGES-007-HOUSE_OVERSIGHT_024013.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

New Leaf team five years ago and has made significant contributions to the NLV-II portfolio. Jim Niedel MD PhD has worked with the team continuously for over twelve years and will continue to be a senior member of the NLV investment team for NLV-III, but will change his status to...

Explaining our taste for excessive harm
document TEXT-001-HOUSE_OVERSIGHT_012747.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Explaining our taste for excessive harm Marc D. Hauser Viking/Penguin For Jacques and Bert Hauser, my parents, my friends, and my reminder that life should be lived to its fullest Hauser Evilicious. Front matter 2 Pleasure is the greatest incentive to evil. ⎯⎯ Plato To witness s...

effective rate greater than 90% of the maximum U.S. corporate income tax rate is not taxable to a
document IMAGES-007-HOUSE_OVERSIGHT_024089.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

effective rate greater than 90% of the maximum U.S. corporate income tax rate is not taxable to a United States Shareholder under the CFC rules if the United States Shareholder so elects. The rules applicable to CFCs are complex, and the foregoing summary of the U.S. federal inc...

Global Asset Allocation
document TEXT-001-HOUSE_OVERSIGHT_026572.txt Nov 9, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

Global Asset Allocation 09 November 2012 The J.P. Morgan View Do US elections change anything? � Asset allocation –– The equity market has priced out the Romney win scenario, but from these levels, our economic and market outlook and risks are unchanged. These keep us medium-ter...